LYMPHOCYTES for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where LYMPHOCYTES was used for Malignant melanoma.
Most Reported Side Effects for LYMPHOCYTES
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 12 | 24.5% | 0 | 3 |
| Disease progression | 7 | 14.3% | 1 | 2 |
| Pneumonia | 7 | 14.3% | 3 | 1 |
| Acute graft versus host disease | 6 | 12.2% | 0 | 0 |
| Hypertension | 6 | 12.2% | 0 | 1 |
| Sepsis | 6 | 12.2% | 1 | 1 |
| Bacterial infection | 5 | 10.2% | 0 | 0 |
| Chronic graft versus host disease | 5 | 10.2% | 0 | 0 |
| Dry eye | 5 | 10.2% | 0 | 0 |
| Dysphagia | 5 | 10.2% | 0 | 0 |
| Extremity contracture | 5 | 10.2% | 0 | 0 |
| Eye irritation | 5 | 10.2% | 0 | 0 |
| Pain | 5 | 10.2% | 0 | 0 |
| Quality of life decreased | 5 | 10.2% | 0 | 0 |
Other Indications for LYMPHOCYTES
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)